Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Triple Negative Breast Neoplasms × capmatinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 11 Melanoma 3 Adenocarcinoma of Lung 3 Lung Neoplasms 2 Noonan Syndrome 6 1 Neoplasm Metastasis 1 Malignant Non-small Cell Neoplasm of Lung Stage IV 1 Liver Neoplasms 1 Kidney Neoplasms 1 Gliosarcoma 1 Glioblastoma 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

pembrolizumab 37 Paclitaxel 36 Carboplatin 31 Cyclophosphamide 22 Albumin-Bound Paclitaxel 20 atezolizumab 16 130-nm albumin-bound paclitaxel 16 Taxes 15 Doxorubicin 15 Cisplatin 13 Capecitabine 13 Nivolumab 9 Docetaxel 8 olaparib 7 Gemcitabine 6 Everolimus 6 talazoparib 5 durvalumab 5 Biopsy 5 Bevacizumab 5 veliparib 4 spartalizumab 4 sacituzumab govitecan 4 pegfilgrastim 4 liposomal doxorubicin 4 eribulin 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 trilaciclib 3 entinostat 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡